Recognizing the serious consequences with regard to the reanalysis of the London 2012 and Beijing 2008 Olympic Games samples, the IWF Executive Board dedicates a full day to discuss these and other Anti-Doping related matters at its meeting in Tbilisi, GEO on 22-23 June. Following the decisions from 2015 that already showed the strictest approach […]
The IWF reports that as a consequence of the IOC’s reanalyses of samples from the 2008 Beijing Olympic Games, the samples of the following Athletes have returned Adverse Analytical Findings: KHURSHUDYAN, Hripsime (ARM) – Stanozolol (S1.1 Anabolic agents) DUDOGLO, Alexandru (MDA) – Stanozolol (S1.1 Anabolic agents) EVSTYUKHINA, Nadezda (RUS) – dehydrochlormethyltestosterone metabolites (S1.1 Anabolic agents) […]
The IWF reports that as a consequence of the IOC’s reanalyses of samples from the 2012 London Olympic Games, the samples of the following Athletes have returned Adverse Analytical Findings: AUKHADOV, Apti (RUS) – Dehydrochlormethyltestosterone, Drostanolone (S1.1 Anabolic agents) KOSTOVA, Boyanka (AZE) – Dehydrochlormethyltestosterone, Stanozolol (S1.1 Anabolic agents) PODOBEDOVA, Svetlana (KAZ) – Stanozolol (S1.1 Anabolic […]
The IWF reports that sample of Mr. Marzoq Adham Badr Masood (YEM) has returned an Adverse Analytical Finding for (S1.1 Anabolic Agents) mesterolone and stanozolol. As a consequence, the athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the athlete did not commit an […]
The IWF has been notified by the IOC regarding presumed Adverse Analytical Findings and Adverse Analytical Findings that resulted from the retesting of the 2008 Beijing and 2012 London Olympic Games samples that also involves medal winners. The IWF closely cooperated with the IOC in the overall retesting procedure. As for Beijing, the results are qualified […]